Investment in Mo-99 production continues to expand in the USA

Janesville, Wisconsin’s SHINE Medical Technologies LLC, announced it has secured an additional $50 million in capital financing from Oaktree Capital Management of Los Angeles.  Having raised over $200 million from investors and grants, SHINE broke ground on its new facility in May of this year and expects to be producing Mo-99 in 2022.  The company forecasts this facility will meet as much as one third of the world’s requirement for Mo-99.

https://www.bizjournals.com/milwaukee/news/2019/10/08/shine-medical-secures-50m-in-additional-funding.html?ana=smartbrief